Non-invasive Aesthetic Treatment Market Summary
The global non-invasive aesthetic treatment market size was estimated at USD 35.99 billion in 2025 and is projected to reach USD 64.07 billion by 2033, growing at a CAGR of 7.45% from 2026 to 2033. This is driven by rising consumer demand for low-risk cosmetic enhancements, technological advancements, and changing lifestyle preferences.
Social media and increased aesthetic awareness, especially among younger people, are making routine cosmetic maintenance more common. In addition, the aging population's interest in subtle anti-aging solutions, combined with the wider availability of treatments in medical spas, dermatology clinics, and retail health settings, also contributes to market growth.
Moreover, rising disposable incomes and a focus on self-care and wellness are driving demand, making non-invasive aesthetic treatments a regular part of lifestyle and wellbeing routines.
Global Non-invasive Aesthetic Treatment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global non-invasive aesthetic treatment market report based on procedure, end use, and region:
- Procedure Outlook (Revenue, USD Million, 2021 - 2033)
- Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Other Skin Rejuvenation Procedures
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital/Surgery Center
- MedSpa
- Traditional Spa
- HCP owned clinic
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources & Third-Party Perspectives
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.5. Information Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Data Visualization
- 1.7. Data Validation & Publishing
- 1.8. List of Abbreviations
- 1.9. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segmental Snapshot
- 2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.2. Non-invasive Aesthetic Treatment Market - Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing beauty consciousness among consumers
- 3.2.1.2. Growing geriatric population
- 3.2.1.3. Increasing adoption of minimally invasive procedures
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Lack of reimbursement coverage
- 3.3. Industry Analysis Tools: Non-invasive Aesthetic Treatment Market
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PEST Analysis
- 3.4. COVID-19 Impact Analysis
Chapter 4. Non-invasive Aesthetic Treatment Market: Procedure Estimates & Trend Analysis
- 4.1. Non-invasive Aesthetic Treatment Market, By Procedure: Key Takeaways
- 4.2. Non-invasive Aesthetic Treatment Market: Procedure Movement & Market Share Analysis, 2025 & 2033
- 4.3. Injectables
- 4.3.1. Global Injectables Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.2. Botulinum Toxin
- 4.3.2.1. Global Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.3. Calcium Hydroxylapatite
- 4.3.3.1. Global Calcium Hydroxylapatite Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.4. Hyaluronic Acid
- 4.3.4.1. Global Hyaluronic Acid Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.5. Polymer Filler
- 4.3.5.1. Global Polymer Filler Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.3.6. Collagen
- 4.3.6.1. Global Collagen Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4. Skin Rejuvenation
- 4.4.1. Global Skin Rejuvenation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4.2. Chemical Peel
- 4.4.2.1. Global Chemical PeelMarket Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4.3. Laser Skin Resurfacing
- 4.4.3.1. Global Laser Skin Resurfacing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.4.4. Photorejuvenation
- 4.4.4.1. Global Photorejuvenation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5. Others
- 4.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.2. Hair Removal
- 4.5.2.1. Global Hair Removal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.3. Nonsurgical Fat Reduction
- 4.5.3.1. Global Nonsurgical Fat Reduction Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.4. Sclerotherapy
- 4.5.4.1. Global Sclerotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 4.5.5. Cellulite Treatment
- 4.5.5.1. Global Cellulite Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Non-invasive Aesthetic Treatment Market: End Use Estimates & Trend Analysis
- 5.1. Non-invasive Aesthetic Treatment Market, By End Use: Key Takeaways
- 5.2. Non-invasive Aesthetic Treatment Market: End Use Movement & Market Share Analysis, 2025 & 2033
- 5.3. Hospital/Surgery Center
- 5.3.1. Global Hospital/Surgery Center Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.4. Medspa
- 5.4.1. Global Medspa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.5. Traditional Spa
- 5.5.1. Global Traditional Spa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 5.6. HCP owned clinic
- 5.6.1. Global HCP owned clinic Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 6. Non-invasive Aesthetic Treatment Market: Regional Estimates & Trend Analysis
- 6.1. Non-invasive Aesthetic Treatment Market: Regional Movement Analysis, 2025 & 2033
- 6.2. North America
- 6.2.1. North America Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.2.2. U.S.
- 6.2.2.1. Key Country Dynamics
- 6.2.2.2. Competitive Scenario
- 6.2.2.3. U.S. Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.2.3. Canada
- 6.2.3.1. Key Country Dynamics
- 6.2.3.2. Competitive Scenario
- 6.2.3.3. Canada Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.2.4. Mexico
- 6.2.4.1. Key Country Dynamics
- 6.2.4.2. Competitive Scenario
- 6.2.4.3. Mexico Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3. Europe
- 6.3.1. Europe Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.2. UK
- 6.3.2.1. Key Country Dynamics
- 6.3.2.2. Competitive Scenario
- 6.3.2.3. UK Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.3. Germany
- 6.3.3.1. Key Country Dynamics
- 6.3.3.2. Competitive Scenario
- 6.3.3.3. Germany Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.4. France
- 6.3.4.1. Key Country Dynamics
- 6.3.4.2. Competitive Scenario
- 6.3.4.3. France Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.5. Italy
- 6.3.5.1. Key Country Dynamics
- 6.3.5.2. Competitive Scenario
- 6.3.5.3. Italy Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.6. Spain
- 6.3.6.1. Key Country Dynamics
- 6.3.6.2. Competitive Scenario
- 6.3.6.3. Spain Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.7. Denmark
- 6.3.7.1. Key Country Dynamics
- 6.3.7.2. Competitive Scenario
- 6.3.7.3. Denmark Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.8. Sweden
- 6.3.8.1. Key Country Dynamics
- 6.3.8.2. Competitive Scenario
- 6.3.8.3. Sweden Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.3.9. Norway
- 6.3.9.1. Key Country Dynamics
- 6.3.9.2. Competitive Scenario
- 6.3.9.3. Norway Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.2. Japan
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Competitive Scenario
- 6.4.2.3. Japan Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.3. China
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Competitive Scenario
- 6.4.3.3. China Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.4. India
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Competitive Scenario
- 6.4.4.3. India Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.5. Australia
- 6.4.5.1. Key Country Dynamics
- 6.4.5.2. Competitive Scenario
- 6.4.5.3. Australia Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.6. Thailand
- 6.4.6.1. Key Country Dynamics
- 6.4.6.2. Competitive Scenario
- 6.4.6.3. Thailand Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.4.7. South Korea
- 6.4.7.1. Key Country Dynamics
- 6.4.7.2. Competitive Scenario
- 6.4.7.3. South Korea Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.5. Latin America
- 6.5.1. Latin America Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.5.2. Brazil
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Competitive Scenario
- 6.5.2.3. Brazil Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.5.3. Argentina
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Competitive Scenario
- 6.5.3.3. Argentina Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6. Middle East & Africa
- 6.6.1. Middle East & Africa Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.2. South Africa
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Competitive Scenario
- 6.6.2.3. South Africa Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.3. Saudi Arabia
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Competitive Scenario
- 6.6.3.3. Saudi Arabia Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.4. UAE
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Competitive Scenario
- 6.6.4.3. UAE Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 6.6.5. Kuwait
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Competitive Scenario
- 6.6.5.3. Kuwait Non-invasive Aesthetic Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Non-invasive Aesthetic Treatment Market: Competitive Landscape
- 7.1. Company Categorization
- 7.2. Company Market Share Analysis, 2025
- 7.3. Strategy Mapping
- 7.4. Company Profiles/Listing
- 7.4.1. Hologic, Inc.
- 7.4.1.1. Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Service Benchmarking
- 7.4.1.4. Strategic Initiatives
- 7.4.2. Allergan, Inc.
- 7.4.2.1. Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Service Benchmarking
- 7.4.2.4. Strategic Initiatives
- 7.4.3. Galderma S.A.
- 7.4.3.1. Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Service Benchmarking
- 7.4.3.4. Strategic Initiatives
- 7.4.4. Alma Lasers
- 7.4.4.1. Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Service Benchmarking
- 7.4.4.4. Strategic Initiatives
- 7.4.5. Syneron Candela
- 7.4.5.1. Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Service Benchmarking
- 7.4.5.4. Strategic Initiatives
- 7.4.6. Johnson & Johnson
- 7.4.6.1. Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Service Benchmarking
- 7.4.6.4. Strategic Initiatives
- 7.4.7. Merz Pharma
- 7.4.7.1. Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Service Benchmarking
- 7.4.7.4. Strategic Initiatives
- 7.4.8. Lumenis
- 7.4.8.1. Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Service Benchmarking
- 7.4.8.4. Strategic Initiatives
- 7.4.9. Solta Medical
- 7.4.9.1. Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Service Benchmarking
- 7.4.9.4. Strategic Initiatives
- 7.4.10. Cutera Inc.
- 7.4.10.1. Overview
- 7.4.10.2. Financial Performance
- 7.4.10.3. Service Benchmarking
- 7.4.10.4. Strategic Initiatives
- 7.4.11. Revance Therapeutics Inc.
- 7.4.11.1. Overview
- 7.4.11.2. Financial Performance
- 7.4.11.3. Service Benchmarking
- 7.4.11.4. Strategic Initiatives